Fertility
Every manufacturer places this the same way.
scroll for all 13 products →
| Section | Zydus Pharmaceuticals UK Ltd1mg Oral Solution | Viatris (formerly Mylan or Upjohn)10mg Tablets | Ipca Laboratories UK Ltd10mg Tablets | Dr. Reddy's Laboratories (UK) Ltd10mg Tablets | Flamingo Pharma (UK) Ltd10mg Tablets | Sandoz Limited10mg Tablets | Amarox Limited10mg Tablet | Aurobindo Pharma - Milpharm Ltd.10mg Tablets | Rosemont Pharmaceuticals Limited1mg Oral Solution | Amarox Limited5mg Tablets | Sandoz Limited5mg Tablets | Zentiva2.5mg Tablets | Viatris (formerly Mylan or Upjohn)10mg Tablets |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ContraindicatedThe label says it must not be used. | |||||||||||||
| WarningThe label says it can be used, with care. | |||||||||||||
| InteractionThe label says another medicine affects it. | |||||||||||||
| PregnancyThe label gives advice for pregnancy or breastfeeding. | Pregnancy | Pregnancy | Pregnancy | Pregnancy | Pregnancy | Pregnancy | Pregnancy | Pregnancy | Pregnancy | Pregnancy | Pregnancy | Pregnancy | Pregnancy |
| ExcipientThe label lists it as an ingredient, not a restriction. |
- Pregnancy
Source SmPC ↗807–816 of 1121 characters Viatris (formerly Mylan or Upjohn)
Source SmPC ↗811–820 of 1126 characters Source SmPC ↗807–816 of 1121 characters Dr. Reddy's Laboratories (UK) Ltd
Source SmPC ↗808–817 of 1122 characters Source SmPC ↗807–816 of 1121 characters Source SmPC ↗809–818 of 1123 characters Source SmPC ↗807–816 of 1121 characters Aurobindo Pharma - Milpharm Ltd.
Source SmPC ↗813–822 of 1128 characters Rosemont Pharmaceuticals Limited
Source SmPC ↗884–893 of 1199 characters Source SmPC ↗807–816 of 1121 characters Source SmPC ↗809–818 of 1123 characters Source SmPC ↗806–815 of 1120 characters Viatris (formerly Mylan or Upjohn)
Source SmPC ↗807–816 of 1121 characters
breast-feeding or to continue/discontinue therapy with amlodipine should be made taking into account the benefit of breast-feeding to the child and the benefit of amlodipine therapy to the mother. Fertility Reversible biochemical changes in the head of spermatozoa have been reported in some patients treated by calcium channel blockers. Clinical data are insufficient regarding the potential effect of a
Identical in all 13 labels. Surrounding text shown from Zydus Pharmaceuticals UK Ltd.